Lemaitre Vascular (LMAT) Shares Outstanding (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Shares Outstanding (Entity) came in at $22.9 million in Q2 2026, up 1.0% year-over-year from $22.6 million in Q2 2025, and little changed quarter-over-quarter from $22.8 million in Q1 2026.
Analysis
Lemaitre Vascular (LMAT) Shares Outstanding (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Shares Outstanding (Entity) for 17 consecutive years, with $22.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 1.0% year-over-year to $22.9 million in Q2 2026; TTM through Jun 2026 was $22.9 million, a 1.0% increase from a year earlier, with the FY2025 full-year figure at $22.8 million, up 0.99% from the prior year.
- Shares Outstanding (Entity) was $22.9 million for Q2 2026 at Lemaitre Vascular, roughly flat from $22.8 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $22.9 million in Q2 2026 and troughed at $22.0 million in Q1 2022.
- A 5-year average of $22.4 million and a median of $22.5 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) grew 6.53% in 2022 and rose 0.66% in 2025, its largest moves.
- Over 5 years, Shares Outstanding (Entity) stood at $22.1 million in 2022, then advanced by 1.09% to $22.3 million in 2023, then climbed by 0.95% to $22.5 million in 2024, then gained by 0.99% to $22.8 million in 2025, then increased by 0.41% to $22.9 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $22.9 million (Q2 2026), $22.8 million (Q1 2026), and $22.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn | 22.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.86 Mn |
| Mar 31, 2026 | 22.80 Mn |
| Dec 31, 2025 | 22.64 Mn |
| Sep 30, 2025 | 22.66 Mn |
| Jun 30, 2025 | 22.61 Mn |
| Mar 31, 2025 | 22.57 Mn |
| Dec 31, 2024 | 22.45 Mn |
| Sep 30, 2024 | 22.48 Mn |
| Jun 30, 2024 | 22.46 Mn |
| Mar 31, 2024 | 22.37 Mn |
| Dec 31, 2023 | 22.22 Mn |
| Sep 30, 2023 | 22.26 Mn |
| Jun 30, 2023 | 22.21 Mn |
| Mar 31, 2023 | 22.11 Mn |
| Dec 31, 2022 | 21.98 Mn |
| Sep 30, 2022 | 21.98 Mn |
| Jun 30, 2022 | 21.96 Mn |
| Mar 31, 2022 | 21.94 Mn |
| Dec 31, 2021 | 21.16 Mn |
| Sep 30, 2021 | 21.59 Mn |